Metformin’s Potential in Pregnancy
Obesity during pregnancy has been a rising concern, often leading to complications like Gestational Diabetes Mellitus (GDM). The study titled “Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women” delves deep into the potential of Metformin as a preventive measure.
The Source Article Details
Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women by Willian Barbosa Sales et al. in 2018.
Cited By: 11 (Updated: November 27, 2023)
The Source Article's Abstract
ObjectiveTo assess the effectiveness of metformin in the incidence of gestational diabetes mellitus (GDM) in obese pregnant women attending a public maternity hospital in Joinville, Santa Catarina, Brazil.
MethodsRandomized clinical trial including obese pregnant women with a body mass index (BMI) â¥ 30 kg/m2, divided into two groups (control and metformin). Both groups received guidance regarding diet and physical exercise. The participants were assessed at two moments, the first at enrollment (gestational ageââ¤â20) and the second at gestational weeks 24â28. The outcomes assessed were BMI and gestational diabetes mellitus (GDM) diagnosis. The data distribution was assessed with the Friedman test. For all the analytical models, the p-values were considered significant when lower than 0.05. The absolute risk reduction was also estimated.
ResultsOverall, 164 pregnant women were assessed and further divided into 82 participants per group. No significant difference was observed in BMI variation between the control and metformin groups (0.9âÂ±â1.2 versus 1.0âÂ±â0.9, respectively, pâ=â0.63). Gestational diabetes mellitus was diagnosed in 15.9% (nâ=â13) of the patients allocated to the metformin group and 19.5% (nâ=â16) of those in the control group (pâ=â0.683). The absolute risk reduction was 3.6 (95% confidence interval 8.0â15.32) in the group treated with metformin, which was not significant.
ConclusionMetformin was not effective in reducing BMI and preventing GDM in obese pregnant women.
The Source Article References
- Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants by M Cesare, 2016 in Lancet
- Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility by J Hajagos-Tóth, 2017 in Croat Med J
- Effect of maternal obesity on foetal growth and metabolic health of the offspring by C Maffeis, 2017 in Obes Facts
- Efficacy of metformin in pregnant obese women: a randomised controlled trial by C A Chiswick, 2015 in BMJ Open
- Gestational diabetes mellitus: does an effective prevention strategy exist? by R Agha-Jaffar, 2016 in Nat Rev Endocrinol
- Metformin compared with glyburide for the management of gestational diabetes by J C Silva, 2010 in Int J Gynaecol Obstet
- Eficácia da metformina no tratamento do diabetes mellitus gestacional by W B Sales, 2015 in Rev Bras Pesqui Saúde.
- Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish gestational diabetes prevention study (RADIEL): a randomized controlled trial by S B Koivusalo, 2016 in Diabetes Care
- Metformin versus placebo in obese pregnant women without diabetes mellitus by A Syngelaki, 2016 in N Engl J Med
- Effects of diet and metformin on placental morphology in gestational diabetes mellitus by R Arshad, 2016 in Pak J Med Sci
- The emerging role of metformin in gestational diabetes mellitus by S G Gray, 2017 in Diabetes Obes Metab
- Efficacy and safety of metformin in weight loss in bahraini population by S M Al-Qallaf, 2016 in J Appl Pharm Sci
- Can metformin limit weight gain in the obese with pregnancy? by E AA El Fattah, 2016 in Int J Reprod Contracept Obstet Gynecol
- CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials by K F Schulz, 2010 in BMJ
- Metformin versus insulin in the management of pre-gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial by T Beyuo, 2015 in PLoS One
- Diabetes: insulin plus metformin for T2DM--are there benefits? by C J Bailey, 2012 in Nat Rev Endocrinol
- Use of oral anti-diabetic agents in pregnancy: a pragmatic approach by B Kalra, 2015 in N Am J Med Sci
- Metformin versus insulin in gestational diabetes mellitus: a meta-analysis of randomized clinical trials by B Zhu, 2016 in Ir J Med Sci
- Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial by D S Feig, 2016 in BMC Pregnancy Childbirth
- Change in level of physical activity during pregnancy in obese women: findings from the UPBEAT pilot trial by L Hayes, 2015 in BMC Pregnancy Childbirth
Citing the Source Article (APA)
Sales, W.B., Nascimento, I.B.d., Dienstmann, G., Souza, M.L.R.d., Silva, G.D.d., Silva, J.C. (2018). Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women. Revista brasileira de ginecologia e obstetricia, 40(4), 180-187. 10.1055/s-0038-1642632
The Study’s Approach
The research was a randomized clinical trial that involved obese pregnant women. These women were divided into two groups: one receiving metformin and the other acting as a control. Both groups were given guidance on diet and physical exercise. The primary aim was to observe any significant difference in the incidence of GDM between the two groups.
The results were intriguing. There was no significant difference in the BMI variation between the two groups. Moreover, the incidence of GDM was almost similar in both groups, indicating that Metformin might not have the desired preventive effect against GDM in obese pregnant women.
Implications for the Medical Field
- Metformin, though widely used for various conditions, might not be the silver bullet for preventing GDM in obese pregnant women.
- More comprehensive studies might be needed to ascertain the exact role of Metformin in such scenarios.
- It emphasizes the need for alternative preventive measures and strategies.
While the study provides valuable insights, it also raises questions about the broader applications of Metformin. It’s crucial for medical professionals to be aware of these findings and consider them when advising obese pregnant women.
What are your thoughts on these findings? How do you think they will shape future research and treatment strategies? Share your insights below.